Similar potency of carbamazepine, oxcarbazepine, and lamotrigine in inhibiting the release of glutamate and other neurotransmitters
- 1 October 1995
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 45 (10) , 1907-1913
- https://doi.org/10.1212/wnl.45.10.1907
Abstract
We compared the effects of the antiepileptic drugs carbamazepine, oxcarbazepine, and lamotrigine on the release from rat brain slices of endogenous glutamate, [(3) H]-GABA, and [(3) H]-dopamine, elicited by the Naplus channel opener, veratrine, and of the same transmitters as well as [(3) H]-noradrenaline, [(3) H]-5-hydroxytryptamine, and [(3) H]-acetylcholine, elicited by electrical stimulation. The three antiepileptic drugs inhibited veratrine-induced release of endogenous glutamate, [(3) H]-GABA, and [(3) H]-dopamine, with IC50 values between 23 and 150 micro Meter, in or near the concentration range in which they interact with Naplus channels, and there was little difference between the compounds. They were five to seven times less potent in inhibiting electrically as compared with veratrine-stimulated release of [(3) H]-GABA and [(3) H]-dopamine; similarly, carbamazepine and tetrodotoxin were more potent in inhibiting veratrine-induced as compared with electrically induced release of endogenous glutamate. Carbamazepine, oxcarbazepine, and lamotrigine also inhibited electrically stimulated release of [(3) H]-5-hydroxytryptamine (IC50 values, 150 to 250 micro Meter) and [(3) H]-acetylcholine (IC50 values, 50 to 150 micro Meter); [(3) H]-noradrenaline release was affected to a lesser degree. The active concentration ranges of these drugs with respect to inhibition of veratrine-stimulated neurotransmitter release matched the therapeutic plasma and brain concentrations. It is uncertain whether these effects are relevant in vivo at anticonvulsant doses, because the drugs are markedly less potent in inhibiting the more physiologic release elicited by electrical stimulation. Therefore, the hypothesis that inhibition of glutamate release is the mechanism of anticonvulsant action of lamotrigine (or carbamazepine and oxcarbazepine) is doubtful. Other consequences of Naplus channel blockade may have an important role. NEUROLOGY 1995;45: 1097-1913Keywords
This publication has 13 references indexed in Scilit:
- Oxcarbazepine: Preclinical Anticonvulsant Profile and Putative Mechanisms of ActionEpilepsia, 1994
- Mechanisms of Action of Currently Prescribed and Newly Developed Antiepileptic DrugsEpilepsia, 1994
- Oxcarbazepine: Mechanisms of ActionEpilepsia, 1994
- Conclusions: The Future Role of OxcarbazepineEpilepsia, 1994
- Mode of action of interleukin-1 in suppression of pituitary LH release in castrated male ratsBrain Research, 1993
- Chemical systems for delivery of antiepileptic drugs to the central nervous systemEpilepsy Research, 1992
- Neurochemical and Behavioral Aspects of LamotrigineEpilepsia, 1991
- Evidence for crosstolerance to the analgesic effects between morphine and selective ?2-adrenoceptor agonistsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1988
- Epileptogenesis and the Immature BrainEpilepsia, 1987
- Calcification of Entheses Associated with X-Linked Hypophosphatemic OsteomalaciaNew England Journal of Medicine, 1985